Related Experiment Videos
Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent
1Cell and Molecular Biology, Pharmacia and Upjohn, Inc., Kalamazoo, MI 49001, USA.
Abstract:
Cell cycle progression in mammalian cells is regulated by a family of cyclin-dependent kinases (cdks) that are activated by a family of 3 cdc25 phosphatases: cdc25A, cdc25B and cdc25C. We examined the expression of mRNA and protein of all 3 cdc25s during the HeLa cell cycle, and found that cdc25B protein has a unique and limited pattern of expression relative to other cdc25 homologs. Antisense oligonucleotides reduced cdc25B mRNA levels and dysregulated protein expression, while inhibiting S-phase progression in synchronized HeLa cells. Scrambled control oligonucleotides had no effect. Antisense oligonucleotides transfected in early G2-phase had no effect on cell cycle progression. A direct correlation between down-regulation of cdc25B and inhibition of thymidine incorporation was found using several oligonucleotides. Our results suggest a role for cdc25B in S-phase and demonstrate that inhibition of cdc25B has persistent antiproliferative effects.
Insights
The study found that cdc25B protein plays a crucial role in S-phase progression in HeLa cells. Inhibiting cdc25B with antisense oligonucleotides led to persistent antiproliferative effects, highlighting its potential as a therapeutic target.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Mammalian cell cycle progression is tightly regulated by cyclin-dependent kinases (cdks).
- Cdc25 phosphatases (cdc25A, cdc25B, cdc25C) are key activators of cdks, controlling cell cycle transitions.
- Understanding the specific roles of each cdc25 phosphatase is crucial for comprehending cell cycle regulation.
Purpose of the Study:
- To investigate the expression patterns of cdc25A, cdc25B, and cdc25C during the HeLa cell cycle.
- To elucidate the specific function of cdc25B in cell cycle progression, particularly during S-phase.
- To evaluate the antiproliferative effects of inhibiting cdc25B expression.
Main Methods:
- Quantitative analysis of cdc25A, cdc25B, and cdc25C mRNA and protein expression in synchronized HeLa cells.
- Application of antisense oligonucleotides to specifically reduce cdc25B mRNA levels.
- Assessment of cell cycle progression using thymidine incorporation assays.
- Evaluation of the impact of cdc25B inhibition on cell proliferation.
Main Results:
- Cdc25B protein exhibited a unique and restricted expression pattern compared to cdc25A and cdc25C during the HeLa cell cycle.
- Down-regulation of cdc25B mRNA and protein using antisense oligonucleotides resulted in the inhibition of S-phase progression.
- Antisense oligonucleotides targeting cdc25B showed no effect on cell cycle progression when applied in early G2-phase.
- A direct correlation was observed between reduced cdc25B levels and inhibited thymidine incorporation, indicating S-phase arrest.
- Inhibition of cdc25B demonstrated persistent antiproliferative effects.
Conclusions:
- Cdc25B plays a significant role in regulating S-phase progression in mammalian cells.
- Targeting cdc25B with antisense oligonucleotides can effectively inhibit cell proliferation.
- These findings suggest that cdc25B is a potential target for antiproliferative therapies.